R&D How predictive safety can help patients Adverse events due to drug consumption can damage the physical and mental wellbeing of patients and are a huge economic burden for the healthcare system (Sultana et al., 2013).
R&D Optimisation of signal management in pharmacovigilance Signal management is a fundamental aspect of pharmacovigilance, required by regulatory agencies
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.